Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$345,168
New position
Shares Held
7,200
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#845
of 1,348 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Peak Asset Management, LLC holds $10,550,757 across 7 Drug Manufacturers - General names. NVO ranks #5 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,957 | $4,306,569 | |
| 2 | MRK |
Merck & Co., Inc.
|
21,535 | $2,767,247 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
32,175 | $1,853,923 | |
| 4 | PFE |
Pfizer Inc
|
29,704 | $715,272 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
7,200 | $345,168 | |
| 6 | NVS |
Novartis AG
|
2,000 | $313,440 | |
| 7 | AMGN |
Amgen Inc
|
688 | $249,138 |
All Filings in NVO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $345,168 | 7,200 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||